Genital herpes in men is caused by herpes simplex virus, most often type 2 (HSV-2) but increasingly type 1 (HSV-1), and it affects a substantial share of the male population worldwide. The infection establishes itself permanently in nerve cells near the base of the spine, producing periodic outbreaks of painful sores on the penis, scrotum, or surrounding skin. What makes it especially tricky in men is that the symptoms are frequently mild, absent, or mistaken for something else entirely, meaning many men carry and transmit the virus without knowing it.
Which Virus Type Causes It
For decades, the textbook version was simple: HSV-1 caused cold sores on the mouth, HSV-2 caused genital herpes. That distinction has blurred considerably. In several high-income countries, HSV-1 has become the leading cause of first-episode genital herpes, particularly among adolescents and young adults.1PubMed. From HSV-2 to HSV-1: A change in the epidemiology of genital herpes The shift is largely driven by fewer people acquiring oral HSV-1 in childhood (through casual contact like shared cups), which means they reach sexual maturity without any antibody protection. When they then encounter HSV-1 through oral sex, the virus establishes itself genitally instead of orally.
Data from a six-year study at a Kentucky medical center illustrated the trend: by the end of the study period, nearly a third of male genital herpes cases were caused by HSV-1 rather than HSV-2.2PubMed Central. Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population The distinction matters clinically because HSV-1 genital infections tend to recur less often than HSV-2 genital infections. A man whose genital herpes is caused by HSV-1 might have one outbreak and then go years without another, while HSV-2 genital infections typically produce more frequent recurrences, especially in the first year or two.
What Symptoms Look Like and What Gets Missed
The classic presentation is a cluster of small, painful blisters on the penis, foreskin, or perianal area that break open into shallow ulcers, crust over, and heal within a couple of weeks. A first episode is usually the worst: the sores tend to be more widespread, more painful, and sometimes accompanied by flu-like symptoms such as fever, body aches, and swollen lymph nodes in the groin. Subsequent outbreaks are generally milder and shorter.
But that textbook picture captures only part of the story. A significant number of men with genital herpes never develop recognizable sores. Some experience nothing more than a brief, vague irritation they attribute to friction or a rash. Others present with urethritis, an inflammation of the urethra that causes burning during urination and sometimes a clear mucoid discharge, without any visible lesions at all. In one study comparing herpes-related urethritis to chlamydial urethritis, men with HSV were far more likely to report severe burning during urination and constitutional symptoms like malaise, and to show signs of meatitis (redness and swelling at the urethral opening), but they were less likely to have the thick discharge typically associated with bacterial infections.3Sexually Transmitted Diseases. Clinical Characteristics of Herpes Simplex Virus Urethritis Compared With Chlamydial Urethritis Among Men
This atypical presentation means herpes-related urethritis often goes undiagnosed. A Japanese study documented 13 men with HSV-confirmed urethritis who had no visible herpetic lesions whatsoever; all presented only with painful urination.4PubMed. Clinical courses of herpes simplex virus-induced urethritis in men Given that a large proportion of non-gonococcal urethritis cases have no identified cause, HSV may be a more common culprit than most clinicians realize.5Journal of the American Academy of Dermatology. Urethritis: An underestimated clinical variant of genital herpes in men?
Shedding Without Symptoms
Perhaps the most consequential feature of genital herpes in men is asymptomatic viral shedding. The virus periodically reactivates from its resting place in the sacral nerve ganglia near the base of the spine, travels back down to the genital skin, and is released at the surface, all without causing any noticeable symptoms.6PubMed. Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture A study of men attending a sexual health clinic found that those with evidence of genital herpes shed virus on roughly one in five days overall, and on about one in twenty days even when they felt completely fine.7The Journal of Infectious Diseases. The Spectrum of Genital Herpes Simplex Virus Infection in Men Attending a Sexually Transmitted Disease Clinic
Shedding rates climb higher in men living with HIV. A prospective study of men who have sex with men found that HIV-positive participants had positive genital HSV-2 cultures on about 10% of days, compared to about 3% of days for HIV-negative participants, and the majority of those reactivations were subclinical.8The Journal of Infectious Diseases. Frequency of Symptomatic and Asymptomatic Herpes Simplex Virus Type 2 Reactivations among Human Immunodeficiency Virus—Infected Men This invisible shedding is the main reason herpes spreads so effectively: most transmission occurs when the infected partner has no idea the virus is active.
How Transmission Works Between Partners
Genital herpes passes more easily from men to women than the other way around. In a study of couples where one partner was infected and the other was not, transmission happened in about 17% of couples where the man was the source, compared to about 4% where the woman was the source.9PubMed. Risk factors for the sexual transmission of genital herpes The difference likely reflects anatomical factors: the mucosal lining of the vagina and cervix provides a larger and more vulnerable surface area than penile skin. For men on the receiving end of transmission, the risk per encounter is lower but is not negligible, especially over months or years of a sexual relationship.
One practical implication worth highlighting for men in discordant couples involves pregnancy. If a susceptible pregnant woman acquires genital herpes from her male partner, the risk to the newborn can be serious. Preventing transmission from a male partner to a pregnant woman could reduce the incidence of neonatal herpes by 60% to 80%.10American Journal of Obstetrics & Gynecology. Risk factors for herpes simplex virus transmission to pregnant women: A couples study This makes it especially important for men who know they carry HSV to discuss it with a partner who is or may become pregnant.
Testing and Diagnostic Pitfalls
Getting an accurate diagnosis of genital herpes is less straightforward than you might expect. If visible sores are present, a swab tested by PCR (polymerase chain reaction) is the gold standard and can also determine whether it is HSV-1 or HSV-2. The problem arises when there are no active lesions, which is most of the time for most men.
Blood tests that look for antibodies to HSV-1 and HSV-2 can confirm past infection, but their accuracy is far from perfect, especially for HSV-2. One study comparing antibody tests to PCR confirmation found that the accuracy of HSV-2 antibody testing for detecting HSV-2 infection alone was only about 38%.11PubMed Central. Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes False positives are common with certain commercial tests, particularly at low index values. This means a positive HSV-2 blood test sometimes leads to significant anxiety and disclosure dilemmas based on a result that may be wrong. If you receive a positive antibody test with a low index value and have never had symptoms, confirmatory testing is worth pursuing before making major decisions about disclosure or treatment.
Self-swabbing for shedding studies has also been validated in men, though the detection of human cellular DNA on genital swabs (a marker confirming the swab actually sampled skin cells) was somewhat lower in men than women, at 93% versus 99%.12PubMed Central. High rate of β-globin DNA detection validates self-sampling in HSV shedding studies This is mainly relevant to research, but it underscores that genital anatomy makes sampling trickier in men: penile skin sheds fewer cells per swab than vaginal mucosa.
Treatment Options
There is no cure for genital herpes, but antiviral medications control outbreaks effectively and reduce the risk of passing the virus to a partner. The two main drugs are acyclovir and its prodrug valacyclovir, which is converted into acyclovir in the body but is absorbed much better, allowing for a simpler dosing schedule. A randomized trial found that valacyclovir taken twice daily works just as well as acyclovir taken five times a day, with no detectable difference in healing time or symptom duration.13Sexually Transmitted Infections. Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial Famciclovir is a third option that works similarly.
For recurrent outbreaks, treatment can be used in two ways. Episodic therapy means you keep a prescription on hand and start taking it at the first sign of an outbreak, ideally within 24 hours of the initial tingling or burning. A three-day course of valacyclovir (500 mg twice daily) is as effective as a five-day course for recurrent episodes, with median healing times of about four and a half days either way and roughly a quarter of patients seeing their lesions abort before fully developing.14Clinical Infectious Diseases. Valacyclovir for Episodic Treatment of Genital Herpes: A Shorter 3-Day Treatment Course Compared with 5-Day Treatment Compared to placebo, valacyclovir cut episode length from about six days to four and nearly tripled the speed at which viral shedding stopped.15JAMA Internal Medicine. A Large-Scale, Placebo-Controlled, Dose-Ranging Trial of Peroral Valaciclovir for Episodic Treatment of Recurrent Herpes Genitalis
Suppressive therapy, taken daily regardless of symptoms, is the other approach. In a large trial, daily valacyclovir reduced detectable viral shedding from about 11% of days to about 3% of days and cut recurrence rates by roughly 75%.16PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes Even among people with HSV-2 antibodies who had never been diagnosed with genital herpes (and so might not think of themselves as having the infection), daily valacyclovir reduced subclinical shedding by about 71%.17PubMed. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes Daily suppressive therapy is commonly recommended for men who have frequent outbreaks (more than about six per year) or who have a sexual partner they want to protect from acquiring the virus.
Prevention Beyond Medication
Condoms reduce the risk of HSV-2 transmission, though they cannot eliminate it because herpes sores can appear on areas not covered by a condom. A pooled analysis of clinical trials estimated that consistent condom use reduced the risk of acquiring HSV-2 by about 30% overall.18Archives of Internal Medicine. A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition A separate large prospective study similarly found that participants who used condoms more frequently had a roughly 26% lower risk of acquiring HSV-2.19PubMed. The relationship between condom use and herpes simplex virus acquisition Interestingly, condoms appear to be more protective for male-to-female transmission than for female-to-male: one study found condoms reduced per-act transmission from men to women by about 96%, while the reduction from women to men was a more modest 65% and did not reach clear statistical significance.20PubMed Central. Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant Couples The asymmetry probably reflects the fact that a condom covers the main site of male viral shedding (the penile shaft and glans) fairly well but cannot cover all skin that might contact an infected female partner.
Male circumcision also appears to offer partial protection. A randomized trial in Uganda found that circumcised men had a roughly 28% lower risk of acquiring HSV-2 over two years compared to uncircumcised men.21PubMed Central. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis A review of the evidence put the overall risk reduction for HSV-2 acquisition in circumcised men at about 30%.22PubMed Central. Male circumcision and Sexually transmitted Infections – An update The mechanism is thought to involve the removal of the inner foreskin, which contains a high density of target cells that HSV can infect. This is obviously not a retroactive strategy for men already infected, but it is relevant epidemiologically and in regions where circumcision is being promoted for HIV prevention.
The most effective prevention strategy for discordant couples combines condom use, daily suppressive valacyclovir for the infected partner, and avoiding sex during outbreaks. No single measure eliminates risk entirely, but layering them together substantially reduces it.
The Connection to HIV
One of the most clinically significant complications of genital herpes in men is that it increases vulnerability to HIV. A large systematic review and meta-analysis found that men and women with existing HSV-2 infection were nearly three times as likely to acquire HIV, and those with a recent (incident) HSV-2 infection faced an almost fivefold increase in HIV risk.23PubMed Central. Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis The mechanism is not mysterious: herpes outbreaks disrupt the skin barrier and recruit immune cells to the genital area, the very cells HIV targets. Even during asymptomatic periods, subclinical inflammation from HSV may keep the door slightly ajar. This relationship has made HSV-2 a public health priority in regions with high HIV prevalence, though unfortunately, trials of HSV-2 suppressive therapy have not shown a significant reduction in HIV acquisition.
Coinfections With Other STIs
Men with genital herpes sometimes carry other sexually transmitted infections simultaneously, partly because overlapping risk factors apply to multiple infections. A nationwide Japanese claims database study found that among men with genital herpes, about 5% to 6% also had syphilis, and about 3% had chlamydia.24PubMed Central. The Proportion of Coinfections Among Sexually Transmitted Infections in Japan: A Nationwide Claims Database Study A study from China looking at male outpatients found coinfection rates of HSV-2 with various other organisms including chlamydia and gonorrhea.25PubMed. Analyses of Human papillomavirus, Ureaplasma urealyticum, Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus 2 and coinfections among male outpatients in Kunming, China The practical takeaway: if you are diagnosed with genital herpes, it is reasonable to get tested for other common STIs at the same time, and vice versa.
Stigma, Disclosure, and the Psychological Burden
For many men, the emotional fallout from a genital herpes diagnosis is worse than the physical symptoms. The stigma surrounding herpes is disproportionate to its medical severity, yet it profoundly shapes how people feel about themselves and how they approach sexual relationships. Research developing a formal measure of genital herpes stigma identified four distinct dimensions: personalized stigma (feeling personally devalued), disclosure concerns, negative self-image, and worry about public attitudes.26PubMed Central. Genital herpes stigma: Toward the Measurement and Validation of a highly prevalent yet hidden public health problem
Disclosure is a particular source of anxiety. A survey of members of the UK Herpes Viruses Association found that a high proportion had told their sexual partners about their diagnosis, and in 83% of cases, disclosure did not lead to rejection. Women in the survey reported greater psychological distress than men, though men were not unaffected.27PubMed. Genital herpes – diagnosis, treatments, attitudes and response to disclosure amongst members of the UK Herpes Viruses Association Among men who have sex with men, the dynamics of disclosure attitudes are complex: one study found that men with a personal history of genital herpes were actually less likely to believe that disclosure was necessary and less likely to intend to disclose to potential partners.28PubMed. Genital Herpes Disclosure Attitudes Among Men Who Have Sex with Men The researchers noted this could reflect a normalization of herpes within communities where STI prevalence is higher, or it could represent avoidance driven by the emotional weight of the conversation. Either way, it highlights that disclosure norms are not uniform, and assumptions about how a partner will react are often more catastrophic than reality warrants.
Lysine and Other Non-Prescription Approaches
You will encounter claims online that the amino acid L-lysine prevents or shortens herpes outbreaks. The evidence is mixed. A review of the literature concluded that doses below 1 gram per day, without a low-arginine diet, appear ineffective for preventing outbreaks, while doses above 3 grams per day may improve how patients experience the disease subjectively.29PubMed Central. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence A small double-blind trial using 1,000 mg three times daily for six months did find a statistically significant reduction in the number of herpes recurrences (about 2.4 fewer infections over the trial period), along with reduced severity and faster healing.30Dermatologica. Success of L-Lysine Therapy in Frequently Recurrent Herpes simplex Infection: Treatment and Prophylaxis A larger survey of over 1,500 people self-reporting their experience found that 84% felt lysine prevented recurrence or decreased frequency, though the survey’s design (self-selected participants, no placebo control) makes it hard to separate a genuine effect from a placebo response.31Journal of Antimicrobial Chemotherapy. Subjective response to lysine in the therapy of herpes simplex
Lysine is generally safe, but the evidence is not strong enough to recommend it as a substitute for antiviral medication, especially if you have frequent outbreaks or a susceptible partner. Some men use it as a supplement alongside prescription treatment, which is reasonable, but it should not be the first line of defense.
Drugs in Development
The current antivirals all work by the same basic mechanism: they block the viral enzyme that copies HSV DNA. A newer class of drug targets a different step in viral replication. Pritelivir, a helicase-primase inhibitor, showed striking results in an early trial. At a dose of 75 mg daily, viral shedding was detected on only about 2% of days, compared to about 17% of days on placebo, and the percentage of days with visible genital lesions dropped from 9% to about 1%.32New England Journal of Medicine. Helicase-primase inhibitor pritelivir for HSV-2 infection The drug’s development was paused for several years due to preclinical safety signals in animals but has since resumed, with ongoing trials focusing on immunocompromised patients who do not respond well to existing antivirals. If pritelivir or a related compound eventually reaches the market, it could offer a meaningfully better option for men whose herpes is not adequately controlled by valacyclovir.
An Unexpectedly Ancient Virus
HSV-2 has been with the human lineage far longer than most people assume. Genetic analyses suggest it did not evolve alongside us in the straightforward way HSV-1 did. Instead, HSV-2 appears to have jumped from the ancestor of modern chimpanzees into an extinct human ancestor roughly 1.6 million years ago.33PubMed Central. Evolutionary Origins of Human Herpes Simplex Viruses 1 and 2 After that cross-species leap, the virus diversified within African populations and then a single lineage, carrying fragments of recombined HSV-1 genetic material, accompanied modern humans as they migrated out of Africa.34Molecular Biology and Evolution. Ancient Recombination Events between Human Herpes Simplex Viruses This deep evolutionary history helps explain why the virus is so finely tuned to human biology, establishing lifelong latency in nerve ganglia and reactivating just often enough to find new hosts without killing the current one. It has had over a million years of practice.